Skip to main content
SpringerLink
Log in

Drug-induced pemphigus

  • Chapter
European Handbook of Dermatological Treatments

  • 370 Accesses

Abstract

Drug-induced pemphigus (DIP) is a rare but well-established variety of pemphigus. Several cases have been described worldwide since it was first reported in 1951 in Italy. Two patterns of association have been observed in DIP. In the first group the drug acts as the major aetiological factor, resulting in pemphigus which is usually mild and responds favourably on stopping the drug. In the other group, the drug only acts as a triggering factor in an immunologically and genetically predisposed individual, leading to the development of idiopathic pemphigus, the course of the disease not being influenced thereafter by the removal of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further reading

  • Brenner S, Bialy-Golan A, Anhalt GJ. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997; 36: 919–23

    Google Scholar 

  • Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998; 16 (3): 393–7.

    Article  CAS  Google Scholar 

  • Landau M, Brenner S. Histopathologic findings in drug-induced pemphigus. Am J Dermatopathol 1997; 19 (4): 411–14.

    Article  CAS  Google Scholar 

  • Mutasim DF, Pelc NJ, Anhalt GJ. Drug-induced pemphigus. Dermatol Clin 1993; 11 (3): 463–71.

    CAS  Google Scholar 

  • Ogata K, Nakajima H, Ikeda M et al Drug-induced pemphigus foliaceus with features of pemphigus vulgaris. Br J Dermatol 2001; 144 (2): 421–2.

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, De Angelis E, Lombardi ML. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin Dermatol 1993; 11 (4): 507–13.

    Article  PubMed  CAS  Google Scholar 

  • Toth GG, Jonkman MF. Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins. Br J Dermatol 1999; 141 (3): 583–5.

    Article  CAS  Google Scholar 

Download references

Authors
  1. S. Albert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. ‘A. Sygros’ Hospital, Department of Dermatology, University of Athens, 5, I. Dragoumi Street, 161 21, Athens, Greece

    Andreas D. Katsambas

  2. University Unit Allergology Professional and Environmental Dermatology, University of Florence, Via Alfani 37, 50 121, Florence, Italy

    Torello M. Lotti

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Albert, S., Black, M.M. (2003). Drug-induced pemphigus. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07131-1_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-05657-4

  • Online ISBN: 978-3-662-07131-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation